Icahn School Of Medicine At Mount Sinai
Clinical trials sponsored by Icahn School Of Medicine At Mount Sinai, explained in plain language.
-
Promising drug studied for rare, painful skin ulcers
Disease control TerminatedThis study tested a drug called spesolimab in 5 adults with moderate to severe pyoderma gangrenosum, a rare autoimmune disease that causes painful skin ulcers. The goal was to see if the drug could help ulcers heal by targeting a specific part of the immune system. The study was …
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
Promising AKN treatment trial halted early
Disease control TerminatedThis study tested Duobrii, a steroid-retinoid cream, for early-stage acne keloidalis nuchae (AKN) in 15 adults, mostly men of African descent. The goal was to reduce lesion counts and symptoms like pain and itching over 12 weeks. The trial was terminated early, so results are lim…
Phase: PHASE3 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
NYC school program aims to boost Kids' heart health
Prevention TerminatedThis study tested a health program in New York City elementary schools to help children develop heart-healthy habits. Over 1,200 kids took part in activities focused on better diet, more exercise, good sleep, and avoiding smoke. The goal was to see if the program could improve th…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Prevention
Last updated Apr 28, 2026 13:02 UTC
-
ER migraine relief: could a pill or spray replace the IV?
Symptom relief TerminatedThis study looked at whether two FDA-approved migraine medicines—a dissolving tablet (rimegepant) and a nasal spray (zavegepant)—work well in the emergency department. The goal was to see if they could provide fast pain relief and shorten ER visits compared to standard IV treatme…
Phase: PHASE4 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated May 01, 2026 16:00 UTC
-
Mindfulness therapy for picky eaters? study tests new approach
Knowledge-focused TerminatedThis study looked at whether a family-based mindfulness therapy is practical and helpful for teens aged 12-18 with avoidant/restrictive food intake disorder (ARFID). The therapy aimed to help teens become more aware of body signals and reduce fear of certain foods. The study was …
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated May 01, 2026 15:59 UTC
-
Smart alerts aim to stop Post-Surgery confusion in Memory-Impaired patients
Knowledge-focused TerminatedThis study looked at whether computer alerts in medical records could help doctors follow best practices to prevent postoperative delirium (sudden confusion after surgery) in patients with cognitive impairment (memory or thinking problems). About 7,400 adults with cognitive impai…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:51 UTC